BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19247217)

  • 1. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
    van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
    Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.
    Becker ML; Aarnoudse AJ; Newton-Cheh C; Hofman A; Witteman JC; Uitterlinden AG; Visser LE; Stricker BH
    Pharmacogenet Genomics; 2008 Jul; 18(7):591-7. PubMed ID: 18551039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities.
    Quraishi SA; Schuler GH; Janicki PK
    J Clin Anesth; 2011 Jun; 23(4):297-302. PubMed ID: 21663814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of rs10918594 polymorphisms of nitric oxide synthase 1 adaptor protein (NOS1AP) with QTc interval prolongation during kidney transplantation.
    Kaczmarczyk M; Biernawska J; Zukowski M; Kotfis K; Zegan-Barańska M; Bińczak-Kuleta A; Ciechanowicz A; Brykczyński M; Bohatyrewicz R
    Transplant Proc; 2011 Oct; 43(8):2964-6. PubMed ID: 21996201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
    Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
    Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
    Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
    Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter by Herring and Paterson regarding article, "Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study".
    Herring N; Paterson DJ
    Circulation; 2007 Dec; 116(24):e564; author reply e565. PubMed ID: 18071084
    [No Abstract]   [Full Text] [Related]  

  • 10. SNP association and sequence analysis of the NOS1AP gene in SIDS.
    Osawa M; Kimura R; Hasegawa I; Mukasa N; Satoh F
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S307-8. PubMed ID: 19289301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Esen-Sehir D; Kopf J; Hägele S; Plichta MM; Reif A; Freudenberg F
    Pharmacopsychiatry; 2022 Sep; 55(5):266-273. PubMed ID: 35732169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.
    Becker ML; Visser LE; Newton-Cheh C; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Br J Clin Pharmacol; 2009 Jan; 67(1):61-7. PubMed ID: 19076153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis.
    Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A
    BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
    Earle N; Ingles J; Bagnall RD; Gray B; Crawford J; Smith W; Shelling AN; Love DR; Semsarian C; Skinner JR
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1346-51. PubMed ID: 26332198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
    Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
    Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin.
    Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Newton-Cheh C; Ahmadizar F; Stricker BH
    Pharmacogenomics J; 2022 Feb; 22(1):55-61. PubMed ID: 34616002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.
    Tomás M; Napolitano C; De Giuli L; Bloise R; Subirana I; Malovini A; Bellazzi R; Arking DE; Marban E; Chakravarti A; Spooner PM; Priori SG
    J Am Coll Cardiol; 2010 Jun; 55(24):2745-52. PubMed ID: 20538168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High free thyroxine levels are associated with QTc prolongation in males.
    van Noord C; van der Deure WM; Sturkenboom MC; Straus SM; Hofman A; Visser TJ; Kors JA; Witteman JC; Stricker BH
    J Endocrinol; 2008 Jul; 198(1):253-60. PubMed ID: 18463146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters.
    Porthan K; Marjamaa A; Viitasalo M; Väänänen H; Jula A; Toivonen L; Nieminen MS; Newton-Cheh C; Salomaa V; Kontula K; Oikarinen L
    Heart Rhythm; 2010 Jul; 7(7):898-903. PubMed ID: 20215044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.